51 research outputs found

    Lung volume recruitment acutely increases respiratory system compliance in individuals with severe respiratory muscle weakness

    No full text
    The aim of the present study was to determine whether lung volume recruitment (LVR) acutely increases respiratory system compliance (Crs) in individuals with severe respiratory muscle weakness (RMW). Individuals with RMW resulting from neuromuscular disease or quadriplegia (n=12) and healthy controls (n=12) underwent pulmonary function testing and the measurement of Crs at baseline, immediately after, 1 h after and 2 h after a single standardised session of LVR. The LVR session involved 10 consecutive supramaximal lung inflations with a manual resuscitation bag to the highest tolerable mouth pressure or a maximum of 50 cmH2O. Each LVR inflation was followed by brief breath-hold and a maximal expiration to residual volume. At baseline, individuals with RMW had lower Crs than controls (37±5 cmH2O versus 109±10 mL·cmH2O−1, p0.05). LVR had no significant effect on measures of pulmonary function at any time point in either group (all p>0.05). During inflations, mean arterial pressure decreased significantly relative to baseline by 10.4±2.8 mmHg and 17.3±3.0 mmHg in individuals with RMW and controls, respectively (both p<0.05). LVR acutely increases Crs in individuals with RMW. However, the high airway pressures during inflations cause reductions in mean arterial pressure that should be considered when applying this technique

    Pectoralis muscle area and its association with indices of disease severity in interstitial lung disease.

    No full text
    RATIONALE The pathophysiology of interstitial lung disease (ILD) impacts body composition, whereby ILD severity is linked to lower lean mass. OBJECTIVES To determine i) if pectoralis muscle area (PMA) is a surrogate for whole-body lean mass in ILD, ii) whether PMA is associated with ILD severity, and iii) if the longitudinal change in PMA is associated with pulmonary function and mortality in ILD. METHODS Patients with ILD (n = 164) were analyzed retrospectively. PMA was quantified from a chest computed tomography scan. Peripheral oxygen saturation (SpO2), 6-min walk distance (6MWD), and pulmonary function were obtained as part of routine clinical care. Dyspnea and quality of life were assessed using the UCSD Shortness of Breath Questionnaire and European Quality of Life 5 Dimensions questionnaire, respectively. RESULTS PMA was associated with whole-body lean mass (p  0.05). The annual negative PMA slope was associated with annual negative slopes in FVC, FEV1, and DLCO (all p < 0.05), but not FEV1/FVC (p = 0.46). Annual slope in PMA was associated with all-cause mortality (hazard ratio = -0.80, 95% CI:0.889-0.959; p < 0.001). CONCLUSION In patients with ILD, PMA is a suitable surrogate for whole-body lean mass. A lower PMA is associated with indices of ILD severity, which supports the notion that ILD progression may involve sarcopenia

    NORSAT-2: Enabling Advanced Maritime Communication with VDES

    Get PDF
    Satellite AIS is well recognized as a system for vessel traffic monitoring and maritime safety. The growing demand for maritime data services has led to the development of a new VHF Data Exchange System (VDES), which will provide two-way communication at higher data rates than possible with current AIS systems. Within the VHF maritime frequency band (156.025-162.025 MHz), VDES integrates AIS with Application Specific Messages (ASM) channels, which have higher capacity and increased reliability. VDES will support the distribution of maritime data, including meteorological and hydrographic data and traffic information. Expanding VDES to a satellite platform will facilitate a global data exchange between ships and shore via satellite. NORSAT-2 is the first satellite to incorporate a VDES payload, in addition to an advanced AIS receiver, both of which are in-orbit reconfigurable software-defined radios developed by Kongsberg Seatex. NORSAT-2 was developed and built by the Space Flight Laboratory (SFL) for Space Norway and the Norwegian Space Centre. With a mass of 16 kg, the satellite design is based on SFL’s Next-generation Earth Monitoring and Observation (NEMO) bus, which has proven flight heritage to be a robust and reliable microsatellite platform. To enable directional communication over VHF for the VDES payload, SFL has developed a three-element deployable Yagi-Uda antenna. The antenna is stowed during launch and deployed on-orbit upon command receipt. In addition to NORSAT-2’s S-band telemetry and command system, the satellite also has an enhanced S-band feeder uplink which is capable of achieving data rates of up to 1 Mbps. NORSAT-2 is scheduled to launch onboard a Soyuz in Q2 2017 into a 600 km polar sun synchronous orbit. It will be the fourth Norwegian satellite on-orbit and is highly anticipated to be one of the first satellites to supply VDES services, in addition to complementing Norway’s existing satellite AIS network. This paper describes the NORSAT-2 mission, with an emphasis on the unique and innovative aspects that are the VDES payload, deployable Yagi antenna, and enhanced S-band uplink

    Therapeutic hypothermia attenuates physiologic, histologic, and metabolomic markers of injury in a porcine model of acute respiratory distress syndrome

    No full text
    Abstract Acute respiratory distress syndrome (ARDS) is a lung injury characterized by noncardiogenic pulmonary edema and hypoxic respiratory failure. The purpose of this study was to investigate the effects of therapeutic hypothermia on short‐term experimental ARDS. Twenty adult female Yorkshire pigs were divided into four groups (n = 5 each): normothermic control (C), normothermic injured (I), hypothermic control (HC), and hypothermic injured (HI). Acute respiratory distress syndrome was induced experimentally via intrapulmonary injection of oleic acid. Target core temperature was achieved in the HI group within 1 h of injury induction. Cardiorespiratory, histologic, cytokine, and metabolomic data were collected on all animals prior to and following injury/sham. All data were collected for approximately 12 h from the beginning of the study until euthanasia. Therapeutic hypothermia reduced injury in the HI compared to the I group (histological injury score = 0.51 ± 0.18 vs. 0.76 ± 0.06; p = 0.02) with no change in gas exchange. All groups expressed distinct phenotypes, with a reduction in pro‐inflammatory metabolites, an increase in anti‐inflammatory metabolites, and a reduction in inflammatory cytokines observed in the HI group compared to the I group. Changes to respiratory system mechanics in the injured groups were due to increases in lung elastance (E) and resistance (R) (ΔE from pre‐injury = 46 ± 14 cmH2O L−1, p < 0.0001; ΔR from pre‐injury: 3 ± 2 cmH2O L−1 s−, p = 0.30) rather than changes to the chest wall (ΔE from pre‐injury: 0.7 ± 1.6 cmH2O L−1, p = 0.99; ΔR from pre‐injury: 0.6 ± 0.1 cmH2O L−1 s−, p = 0.01). Both control groups had no change in respiratory mechanics. In conclusion, therapeutic hypothermia can reduce markers of injury and inflammation associated with experimentally induced short‐term ARDS
    • 

    corecore